Northwire Canada EditionSunday, August 9, 2026
Northwire
WHN 0.375 −2.6% LME 0.140 +3.7% AAUC 30.49 +5.3% GGM 0.040 +14.3% FDY 6.18 +3.2% MOG 0.640 +3.2% NEXM 3.20 +1.3% NCAU 0.330 +3.1% LUC 0.160 +0.0% BTR 0.140 +0.0% SMRV 0.200 −16.7% BIG 0.880 +3.5% URC 3.89 +0.0% ATY 0.250 −2.0% NRM 0.075 +7.1% WMS 0.040 +0.0% WHN 0.375 −2.6% LME 0.140 +3.7% AAUC 30.49 +5.3% GGM 0.040 +14.3% FDY 6.18 +3.2% MOG 0.640 +3.2% NEXM 3.20 +1.3% NCAU 0.330 +3.1% LUC 0.160 +0.0% BTR 0.140 +0.0% SMRV 0.200 −16.7% BIG 0.880 +3.5% URC 3.89 +0.0% ATY 0.250 −2.0% NRM 0.075 +7.1% WMS 0.040 +0.0%
Financings

First Phosphate closes $3.06M 3rd tranche of financing

PHOS · Price

Executive Summary

  • First Phosphate Corp. closed the third tranche of its non-brokered private placement on December 12, 2025, raising $3,066,726 in this specific tranche.
  • The company has now raised a total of $6,637,574 across three tranches, consisting of 5,955,444 flow-through shares and 1,419,638 hard-dollar units.
  • This transaction brings the company's total capital raised through management-led non-brokered private placements since June 2022 to approximately $46.7 million.

Key Details

  • Third Tranche Proceeds: $3,066,726 raised in the current tranche.
  • Third Tranche Composition:
    • Issuance of 2,599,612 flow-through shares for gross proceeds of $2,339,651.
    • Issuance of 807,861 hard-dollar units (comprising 807,861 common shares and 807,861 warrants) for gross proceeds of $727,075.
  • Aggregate Offering (All Three Tranches):
    • Total Gross Proceeds: $6,637,574.
    • Total Flow-Through Shares Issued: 5,955,444 (Gross Proceeds: $5,359,900).
    • Total Hard-Dollar Units Issued: 1,419,638 (Gross Proceeds: $1,277,674).
  • Historical Context: The company has raised approximately $46.7 million in 10 management-led non-brokered private-placement financings since June 2022.
  • Compensation: Issued 8,000 compensation common shares and 8,000 compensation warrants.
    • Exercise Price: $1.25 per common share.
    • Expiry: April 30, 2026 (subject to accelerated expiry date).
  • Regulatory Conditions: All securities are subject to a four-month-and-one-day statutory hold period. Completion is subject to necessary approvals.
  • Use of Proceeds: As disclosed in the press release dated November 7, 2025.
  • Future Discretion: The company may close another tranche of the offering at its discretion.

Notable Quotes

  • None provided in the text.
Read the original news release →

More from First Phosphate Corp